NRBO - NeuroBo Pharmaceuticals, Inc. Net Sales Margin

NRBO (NeuroBo Pharmaceuticals, Inc.) - company brandmark

Actual net profit margins demonstrate the scaling potential of NeuroBo Pharmaceuticals (NRBO) driven by a patent monopoly and low drug synthesis costs. A lean team of scientists and support from an Asian partner ensure the stability of the R&D core. The 0.00 level is recording fresh values amid DA-1726 trials and high demand for MASH and obesity therapies.

NeuroBo Pharmaceuticals (NRBO) Net Profit Rate: for the period 07/04/2022 - 12/07/2024

NRBO (NeuroBo): analytical breakdowns and indicator data

Basic company analysis:NeuroBo Pharma - NRBO
Flagship merchandise of NeuroBo Pharmaceuticals Inc

The investment attractiveness of NeuroBo Pharmaceuticals (NRBO) is based on the potential of its metabolic disorder therapies. This metric determines the share of net profit in total revenue, assessing the ultimate efficiency of cost management. Analyzing the net margin allows for the filtering of temporary fluctuations to identify the real momentum of profitability. For this obesity drug developer, this trend reflects the balance between R&D expenditures and financial returns. The steady growth of the line confirms the fundamental stability of the business model.

Analysis of competing companies

BIIB: Net Sales Margin|Net Margin Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Net Sales Margin|AXSM: Net Profit Rate|Net Margin acadia-pharm.com (ACAD)|Net Sales Margin Xenon Pharmaceuticals (XENE)|Net Margin Viking Therapeutics VKTX|Net Profit Rate SUPN|CPRX - Net Margin|Net Margin Denali Therapeutics|HRMY: Net Sales Margin|Biohaven - Net Profit Rate|Return on Sales by Net Profit AMLX|Trevi Therapeutics, Inc. (TRVI) - Company Sales Margin|Return on Sales by Net Profit PRAX (Praxis Medicines)|Anavex Corp - Net Return on Sales|Net Margin CeriBell CBLL|Company Sales Margin Prothena Biosciences (PRTA)|ALEC: Return on Sales by Net Profit|ANNX - Net Sales Margin|Omeros Corp. (OMER) - Net Margin|Net Margin Neurogene Inc. (NGNE)|Return on Sales by Net Profit ACIU|Net Margin VYGR|Net Margin Neumora (NMRA)|SCLX - Net Margin|Net Sales Margin TVGN (Tevogen Bio Holdings Inc.)|Net Profit Rate ACOG|Cognition Therapeutics Inc. - Net Sales Margin|IKT - Net Sales Margin|SAVA: Net Sales Margin|Assertio Holdings, Inc. - Net Profit Rate|COYA (Coya) - Net Sales Margin|Net Return on Sales VTGN (Vistagen Therapeutics)|Net Margin Ovid Rx (OVID)|Acumen Pharmaceuticals - Net Return on Sales|Net Margin CervoMed, Inc. CRVO|Net Sales Margin Alterity Therapeutics ATHE|CLNN: Return on Sales by Net Profit|PEPG (pepgen.com) - Net Return on Sales|Jupiter Neurosciences Inc (JUNS) - Net Margin|Relmada Therapeutics - Net Profit Rate|ANVS (Annovis Bio Inc) - Net Sales Margin|GRCE: Net Profit Rate|Net Margin Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Net Profit Rate|Net Margin neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Net Margin|MTVA: Return on Sales by Net Profit|NeurAxis, Inc (NRXS) - Return on Sales by Net Profit|HSDT: Net Sales Margin|PASG - Company Sales Margin|Net Margin Neuphoria Therapeutics, Inc.|Net Margin NERV|Net Sales Margin ATHA|ADXN (Addex Therapeutics Ltd) - Net Profit Rate|Net Margin alzamend.com ALZN|Company Sales Margin Cyclerion Therapeutics (CYCN)|Protagenic - Net Sales Margin|Net Profit Rate KTTA (Pasithea Therapeutics Corp)|CRGT: Net Sales Margin|Avenue Therapeutics Inc. (ATXI) - Net Sales Margin|BCLI (BrainStorm Cell Therapeutics Inc.) - Net Sales Margin|Net Sales Margin Cara Therapeutics Inc|Net Margin Chromocell Therapeutics (CHRO)|Company Net Profitability ELYM|Net Margin Intra-Cellular ITCI|LBPH: Net Return on Sales|MRNS - Net Margin|NKGen Biotech, Inc. (NKGN) - Return on Sales by Net Profit|SAGE (Sage Therapeutics, Inc) - Return on Sales by Net Profit|Net Return on Sales SNPX|Return on Sales by Net Profit TRVN|Net Margin VIGL|Net Sales Margin WENA|Company Sales Margin Cerevel